The stock's fall snapped a three-day winning streak.

Google’s Veo 3 AI video generating software is now available to try in Vertex AI in public preview - here’s what you need to ...

"Make the logo bigger" is the most infamous piece of graphic design feedback, one that has plagued designers since the dawn of time. But how do you make a logo bigger without simply adding more pixels ...

A woman claims she was accused of wearing an "inappropriate" outfit at Disney World. A personal trainer visiting one of Disney's theme parks in Orlando, Florida claims that she was told she was ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).

HarbourVest has joined a growing list of corporate names that now grace Boston’s skyline: Foundation Medicine, CarGurus, Eli Lilly, State Street, Whoop, MassMutual.

Vertex, Inc. (NASDAQ: VERX) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Joe Crivelli - Vice President of Investor Relations David DeStefano - President and Chief ...

TORONTO, Sept. 26, 2024 /CNW/ - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor ...

DUBAI, UAE, Nov. 19, 2024 /PRNewswire/ -- The Vertex Companies, LLC ("Vertex"), a portfolio company of Wind Point Partners ("Wind Point"), is pleased to announce the acquisition of CBBG Group ...

Google’s making the second generation of Imagen, its AI model that can create and edit images given a text prompt, more widely available — at least to Google Cloud customers using Vertex AI ...

Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain.

Bradley Sills has given his Hold rating due to a combination of factors including Vertex’s mixed performance in the second quarter and the potential for achieving the rule of 40 in the coming ...